About
Insight Medbotics is an interventional oncology company based in Hamilton, Ontario, founded in 2017. The company specializes in developing advanced MRI-guided robotic systems aimed at improving cancer care. It was established through a partnership between the Centre for Surgical Invention and Innovation and MDA, a prominent Canadian aerospace company. Insight Medbotics combines expertise in space technology and informatics to create intelligent robotic systems for Image Guided Automated Robotics (IGAR), focusing on enhancing the accuracy and precision of cancer diagnosis and treatment. The flagship product, IGAR, is the first MRI-guided robotic system to receive FDA 510(k) clearance. It has been clinically demonstrated for use in breast cancer procedures, including biopsies and targeted therapy delivery. The company is also developing Glenn™, a next-generation MRI-compatible robotics system for prostate cancer care, which aims to streamline the care pathway and improve patient experience. Insight Medbotics collaborates with healthcare professionals to ensure its products meet clinical needs and enhance patient outcomes.
Technologies
Keywords
Company Information
-
Employees 11
-
Founded 2017
Location
39 Charlton Avenue East, Hamilton, Ontario, Canada, L8N 1Y3
